MedPath

Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?

Completed
Conditions
Dizziness
Interventions
Other: LFTs
Registration Number
NCT02733549
Lead Sponsor
Adiyaman University Research Hospital
Brief Summary

Dizziness is one of the most common complaints among patients admitted to the emergency department (ED). In most cases, the etiology remains unclear. Dizziness has a broad differential diagnosis. The initial symptoms of ALD can include many general complaints. Aim of this study is to investigate whether SOD is a symptom of ALD, the necessity of liver function tests for patients with SOD in the ED, and a cost analysis of liver function tests.

Detailed Description

Dizziness is one of the most common complaints among patients admitted to the emergency department (ED). In most cases, the etiology remains unclear. Dizziness has a broad differential diagnosis. The initial symptoms of ALD can include many general complaints. The diagnosis of acute liver dysfunction (ALD) can usually be made by initial symptoms, physical examination, and biochemical tests, including liver function tests (LFTs) with high sensitivity and specificity. LFTs include albumin, bilirubin, coagulation factors (Activated Partial Thromboplastin Time (aPTT) and International Normalized Ratio (INR)), and liver enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphates (ALP), and y-glutamyl transpeptidase (GGT), which are marker of hepatic damage. Aim of this study is to investigate whether SOD is a symptom of ALD, the necessity of LFTs for patients with SOD in the ED, and a cost analysis of LFTs.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
198
Inclusion Criteria
  1. Adult patients who were experiencing sudden onset dizziness of unknown etiology for the first time were included in the study
Exclusion Criteria
  1. Patients with a history of chronic diseases such as any liver disease,diabetes mellitus, hypertension,congestive heart failure, hepatitis B or C infection
  2. Patients with any central dizziness attacks
  3. Patients with hemodynamically unstable and emesis;
  4. Patients receiving drugs that could affect liver function tests, such as, acetaminophen, antibiotics, oral contraceptives, antihypertensive drugs (e.g., angiotensinconverting enzyme inhibitors), or hormones (e.g.,estrogen)
  5. Patients who was experienced dizziness with systemic diseases
  6. Patients with any neurological disorders
  7. Patient who do not want to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patientLFTsPatients with sudden onset dizziness (SOD) analysed LFTs
controlLFTsThe control group with 98 healthy volunteer analysed LFTs
Primary Outcome Measures
NameTimeMethod
LFTs serum levels by biochemical method ALT, AST, ALP, GGT, total bilirubin, conjugated bilirubin, albumin, INR, aPTT, and Platelet count (PC)5 months

The serum levels of LFTs will obtained by the laboratory analysis of blood samples of each participant.

Secondary Outcome Measures
NameTimeMethod
The cost calculation for the LFTs5 months

The cost for the LFTs will be calculated with financial data in invoices which will obtained from the hospital invoicing service.

Trial Locations

Locations (1)

Adiyaman University Research Hospital

🇹🇷

Adiyaman, Central, Turkey

© Copyright 2025. All Rights Reserved by MedPath